Algert Global LLC Meridian Bioscience Inc Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$30.9 - $33.55 $204,094 - $221,597	6,605 Added 77.89%	15,085 $476,000
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $201,400 - $268,731	8,480 New	8,480 $258,000
Q1 2020 May 13, 2020	SELL	$5.57 - $11.5 $115,967 - $239,430	-20,820 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$7.9 - $10.14 $164,478 - $211,114	20,820 New	20,820 $203,000
Q1 2018 May 03, 2018	SELL	$13.8 - $16.2 $297,127 - $348,802	-21,531 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$13.55 - $15.8 $291,745 - $340,189	21,531	21,531 $301,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.